Institutional investors hold a majority ownership of AGN through the 91.94% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2015, these large investors purchased a net $1.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST MANHATTAN CO. Bought 173.3 Thousand shares of Allergan
ETHENEA INDEPENDENT INVESTORS SA Bought 120.0 Thousand shares of Allergan
MID-CONTINENT CAPITAL LLC Bought 69.8 Thousand shares of Allergan